ANAPTYSBIO, INC. Employee Count
The employee counts ANAPTYSBIO, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 104; Filing 2026-03-03; Lease expense per employee $23,826.92.
- 2024-12-31: Employees (as filed) 136; Filing 2025-02-27; Lease expense per employee $18,220.59.
- 2023-12-31: Employees (as filed) 117; Filing 2024-03-11; Lease expense per employee $21.18.
- 2021-12-31: Employees (as filed) 102; Filing 2022-03-07; Lease expense per employee $21,696.08.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 104 | 2026-03-03 | $23,826.92 operating |
| 2024-12-31 | 136 | 2025-02-27 | $18,220.59 operating |
| 2023-12-31 | 117 | 2024-03-11 | $21.18 operating |
| 2021-12-31 | 102 full-time | 2022-03-07 | $21,696.08 operating |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |